Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer. - Wikidata - wikimedia - TriplyDB

Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.

Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.

http://www.wikidata.org/entity/Q37286038

about

Promising oncolytic agents for metastatic breast cancer treatment Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replication Oncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1.Anaplastic thyroid cancer: a comprehensive review of novel therapy.Bugs and drugs: oncolytic virotherapy in combination with chemotherapy.Evolution of oncolytic viruses: novel strategies for cancer treatment.Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model.Oncolytic virotherapy for urological cancers.Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models.Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer.Effect of a caspase inhibitor, zVADfmk, on the inhibition of breast cancer cells by herpes simplex virus type 1.Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells.Model-based rational design of an oncolytic virus with improved therapeutic potential.Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer.

P2860

Q26830620-85377688-033B-40E1-B23B-A58F6B3EF59C Q26863779-BB701824-281A-4CAE-94C4-181A8244F325 Q33566587-4B6CE8D3-019C-4EE3-9E41-46794C1C886F Q33995471-980415F2-24D3-4A0F-934D-DD7196D0CA1F Q35545752-526216F8-4E8E-40BA-A96C-EC7E1C2F05DE Q37031896-7FE7B217-03E6-4DE3-99CB-7E02157ED7B8 Q37160195-B34DB161-C76F-4FEA-BA67-FC23A278662F Q37565501-A8F90B8E-F83E-41E9-A44B-E0E19747837A Q37854708-9FC81022-AA3D-48D2-A7CA-61A09A95B1A4 Q37899223-4B9C65FE-E220-48AB-9A37-D5DC119EC556 Q38159802-A2E2530F-213F-41E0-89AF-9F4FF8EBC172 Q38264652-5BFE3F9D-DFF8-47DB-B477-0021E6B50940 Q38765125-920CF2CF-3836-460D-9DBA-6769EAA7D009 Q38842126-43D64F0C-60CF-47CC-BC8A-8D7891A97B7C Q39247534-1792E953-1D1F-4819-85B0-38A33EAF2D32 Q39315516-E4A970B4-89F8-4397-AD02-534D8FDB8E2D Q39325959-24D37AFD-3903-4064-B308-B69AA5F78CE2 Q39519074-4839586B-1EF9-443B-A001-4185C04A1D17 Q39745964-4D1B25BD-9373-4F70-843A-81C52E61F71A Q45350759-5556004B-F74F-4DF8-9656-A46BB885ED42 Q45360866-C5C45506-6EFE-4975-B4EA-1A62AB6988EC

P2860

Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.

http://www.wikidata.org/entity/Q37286038

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.

@en

Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.

@nl

type

label

Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.

@en

Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.

@nl

prefLabel

Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.

@en

Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.

@nl

P1433

Q37286038-B4A77328-8562-43B7-A908-715D97138E62

P1476

Q37286038-35BF7799-C6D2-4CE3-93B3-8EB8DC027F62

P2093

Q37286038-12EBF3A5-5593-46BD-B398-AA8A8A01054B

Q37286038-A3520F8B-BCCF-45D2-9531-DC32AF206325

Q37286038-A5882077-1901-49ED-B1C3-69D7C3C2DCC3

Q37286038-B4981F2F-2EC0-41D0-A6AB-5CB7D2CC0997

Q37286038-FD38C620-01C7-4C23-9CDD-CFB169C6C22F

P2860

Q37286038-052D1743-29E1-4401-8EA0-392BBE456498

Q37286038-08AD5A31-A635-4F49-8A91-1B91F1091D9F

Q37286038-0B4B4BCE-A2B4-44D5-A47E-FEE2F03D12D9

Q37286038-0DE15AFB-C389-43EC-85DF-543565FD376E

Q37286038-2F018B46-A2B4-4C1D-9D53-B0D99C04FBAF

Q37286038-30291E38-77C8-4561-A51D-C2F83A997383

Q37286038-38EE7828-B63E-4641-925A-671377C233BD

Q37286038-3BE0CAD7-14B9-4839-A624-615F7D6C4312

Q37286038-45F31DD9-01F0-43E8-94B3-26B950BF11E1

Q37286038-4A53C75D-9212-4F16-B3C8-D3DFB305D409

P304

Q37286038-83ABEEED-DD79-4B33-B439-41B7D80627A5

P31

Q37286038-2BF0BABA-BF82-42BE-9AAE-F3D62257020D

P356

Q37286038-98550F2C-83F1-41DE-9371-70DB02FF4F8A

P407

Q37286038-DB4723BF-92AC-4636-8BE8-004008D6ED38

P433

Q37286038-51A148DC-4527-4E45-896E-0C417BC55190

P478

Q37286038-D4BC2DDB-9A4F-45EC-8212-E6A12E4E12EF

P50

Q37286038-0BCDC121-1B52-4620-9DE0-397114CA055E

Q37286038-15399B91-663A-4890-B8C5-B524D6A28531

Q37286038-437467BD-354E-4D4F-8F25-0D3EC0399637

Q37286038-8A4D84EC-F5D3-410F-8053-661B10C25FA3

P577

Q37286038-A2DA6338-BD2A-40CC-B15C-3CAFCC32E8E8

P698

Q37286038-35AC0B0B-35DA-4292-8A31-7A95FEDE2B29

P921

Q37286038-0889BCE2-8598-4304-880A-E8BC01646347

P932

Q37286038-68A314DB-1431-451C-8E44-0EBAA8A26539

P356

1078-0432.CCR-07-4628

P1433

Clinical Cancer Research

P1476

Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer

@en

P2093

Paramjeet Singh

http://www.w3.org/2001/XMLSchema#string

Richard J Wong

http://www.w3.org/2001/XMLSchema#string

Sen Li

http://www.w3.org/2001/XMLSchema#string

Sizhi Paul Gao

http://www.w3.org/2001/XMLSchema#string

Ting-Chao Chou

http://www.w3.org/2001/XMLSchema#string

P2860

Microtubules as a target for anticancer drugs

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

Infection with oncolytic herpes simplex virus-1 induces apoptosis in neighboring human cancer cells: a potential target to increase anticancer activity.

Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus.

Microtubule reorganization during herpes simplex virus type 1 infection facilitates the nuclear localization of VP22, a major virion tegument protein

Combined therapy with chemotherapeutic agents and herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) in human non-small cell lung cancer.

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma.

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial.

Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group.

Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.

P304

1519-1528

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-07-4628

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18316577

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

2719715

http://www.w3.org/2001/XMLSchema#string